Contents
Download PDF
pdf Download XML
777 Views
126 Downloads
Share this article
Case Report | Volume 2 Issue 1 (Jan-June, 2021) | Pages 1 - 2
Case Report: Central Retinal Vein Occlusion in Adpkd
 ,
1
Physician, Regional hospital Reckong peo, Distt kinnaur, Himachal Pradesh, India
2
Eye surgeon, Regional hospital Kullu, Distt kullu, Himachal Pradesh, India
Under a Creative Commons license
Open Access
Received
Dec. 13, 2020
Revised
Jan. 6, 2021
Accepted
Feb. 21, 2021
Published
March 31, 2021
Abstract

Central retinal vein occlusion (CRVO) is one of the major causes of severe vision impairment and blindness. The prevalence of retinal artery or vein occlusion in the general population increases with age. ADPKD patients are at risk for developing central retinal vascular occlusions at a younger age. Here we report a case of ADPKD with central retinal vein occlusion.

Keywords
INTRODUCTION

Central retinal vein occlusion (CRVO) is one of the major causes of severe vision impairment and blindness [1]. The prevalence of retinal artery or vein occlusion in the general population increases with age [2]. The prevalence of central retinal vein occlusion (CRVO) is 0.1 to 0.7 percent in population-based studies [3]. CRVO occurs at 0.7% in persons between 49 and 60 years of age. The prevalence progressively increases to 4.6% in persons older than 80 years [4]. ADPKD patients are at risk for developing central retinal vascular occlusions at a younger age [5]. Autosomal dominant polycystic kidney disease (ADPKD) is a systemic disease with renal and extra renal, cystic and non-cystic manifestations. The cystic disease involves kidney, liver, pancreas, seminal vesicles and meninges [6]. The risk factors for developing  CRVO include hypertension, diabetes, hyperlipidaemia, cigarette smoking, hyperviscosity or hypercoagulable states and hyperhomocysteinaemia [7]. 

 

Case Report

A 53-year-old male presented with a sudden loss of vision in his left eye for last 3 days. The vision loss occurred without any associated symptoms or notable preceding event.He had no prior vision problem. On physical examination, blood pressure was 158/88 mmHg. Visual acuity  in left  eye was counting finger at 1 feet; the right eye was unaffected (OD: 20/20). Pupil examination showed relative afferent pupillary defect in left eye. Intraocular pressures were 12 mm of Hg in right and 18 mm of Hg in left eye. Extraocular movements were normal. Slit examination showed normal anterior segments. Ophthalmoscopic examination of the left  eye revealed pale disc, multiple areas of retinal haemorrhages with venous dilatations adjacent to the disc and cotton wool patches. ( Figure 1). These findings were consistent with combined central retinal vein occlusion (CRVO). Basic investigations were done which revealed azotemia (S.creatinine 2.2 mg/dl). Rest of the baseline investigations were normal. USG Kidneys were done which showed multiple renal cysts  with mild raised cortical echogenicity consistent with signs of polycystic kidney disease. Case was referred to medicine department for same. Diagnosis of adult polycystic kidney disease was made. He was prescribed amlodipine and chlorothiazide for better control of hypertension. He was advised intravitreal injections of bevacizumab and was put on topical antiglaucoma medications.

 

 

Figure 1: Fundus Photograph Showing Pale Disc, Multiple Retinal Hemorrhages and Cotton Wool Spots

 

 

Figure 2: Usg Kidneys Showing Multiple Cysts with Mild Raised Cortical Echogenicity

               

 Apart from a diagnosis of ADPKD, the only predisposing condition was hypertension. We propose that retinal vascular occlusion may be a manifestation of the vasculopathy associated with ADPKD ( Autosomal dominant polycystic kidney disease).

DISCUSSION

CRVO has two types: a) Nonischemic (70%): which is characterized by vision that is better than 20/200, 16% progress to nonperfused; 50% resolve completely without treatment; defined as <10 disk diameter (DD) of capillary nonperfusion. b)Ischemic (30%): which is defined as more than 10 DD of nonperfusion; patients are usually older and have worse vision; 60% develop iris NV; up to 33% develop neovascular glaucoma; 10% are combined with branch retinal arterial occlusion (usually cilioretinal artery due to low perfusion pressure of choroidal system) [8]. Ophthalmoscopic examination typically shows  retinal haemorrhages with venous dilatation and cotton wool spots for CRVO; and retinal/macular oedema. Long-term complications include retinal neovascularization, macular detachment with vitreous haemorrhage and neovascular glaucoma. The final visual acuity depends on the visual acuity at presentation, the duration of visual impairment and the severity of the subsequent complications [9-10].  Qi Qian et al reported  occurrence of central retinal vascular occlusions in eight patients with ADPKD at a median age of 51.2 years, contrasted with an approximately 63–75 years in the general population [2,11]. Retinal vascular occlusion is another manifestation of the systemic vasculopathy in ADPKD. Increased awareness of this manifestation could lead to an earlier diagnosis and treatment before irreversible vision loss develops [11].

CONCLUSION

When a patient less than 50 years of age presents with central retinal vein occlusion, other causes such as ADPKD should be specifically considered. Detailed history taking, supportive examinations and imaging should be performed. Thus thorough examination helps in early diagnosis and prompt treatment may prevent progress of disease and loss of vision.

 

  • Financial support and sponsorship: NIL

  • Conflict of interest: There is no conflict of interest

REFERENCE
  1. The Central Vein Occlusion Study Group. "Natural history and clinical management of central retinal vein occlusion." Arch Ophthalmol, vol. 115, no. 4, 1997, pp. 486–491.

  2. Lorentzen S.E. "Occlusion of the central retinal artery: a follow-up." Acta Ophthalmol (Copenh), vol. 47, no. 6, 1969, pp. 690–703.

  3. Mohamed Q. et al. "Interventions for central retinal vein occlusion: an evidence-based systematic review." Ophthalmology, vol. 114, no. 3, 2007, pp. 507–519. doi:10.1016/j.ophtha.2006.11.011.

  4. Mitchell P. et al. "Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study." Arch Ophthalmol, vol. 114, no. 10, 1996, pp. 1243–1247.

  5. Gabow P.A. et al. "Polycystic kidney disease: prospective analysis of nonazotemic patients and family members." Ann Intern Med, vol. 101, no. 2, 1984, pp. 238–247.

  6. Torres V. et al. "Epidemiology, problems in diagnosis and management of polycystic kidney disease." In: Proceedings of the PKR Foundation, Kansas City, 1985, pp. 49–69.

  7. Colucciello M. "Retinal vascular disease in hypertension: risk factor modification optimizes vision outcomes." Postgrad Med, vol. 117, no. 1, 2005, pp. 33–38, 41–42.

  8. Friedman N. et al. "Central retinal vein occlusion." In: Review of Ophthalmology, 2005, ch. 11, p. 329.

  9. Augsburger J.J., Magargal L.E. "Visual prognosis following treatment of acute central retinal artery obstruction." Br J Ophthalmol, vol. 64, no. 12, 1980, pp. 913–917.

  10. The Central Vein Occlusion Study Group. "Natural history and clinical management of central retinal vein occlusion." Arch Ophthalmol, vol. 115, no. 4, 1997, pp. 486–491.

  11. Qian Q., Younge B.R., Torres V.E. "Retinal arterial and venous occlusions in patients with ADPKD." Nephrol Dial Transplant, vol. 22, no. 6, 2007, pp. 1769–1771.

License
CC BY-NC-ND
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
Case Report: Central Retinal Vein Occlusion in Adpkd © 2026 by Bhagwan Dass Negi, Shaloo Negi licensed under CC BY-NC-ND 4.0
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Himalayan Journal of Applied Medical Sciences and Research open access articles are licensed under a Creative Commons Attribution-Share A like 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Research Article
Digital Implantology: Current Concepts, Clinical Applications, Limitations and Future Directions - A Narrative Review
Published: 30/07/2026
Download PDF
Research Article
Study of the Role of Serum Interleukin-6 in Inflammation among Pregnant Women with COVID-19
Published: 27/07/2021
Download PDF
Research Article
Evalution CD11b, CD4, IL-17A and IL-23 as Biomarkers Immunological in Patients with Behçet’s Disease
...
Published: 13/07/2026
Download PDF
Research Article
Bones in Balance: Awareness of Rickets and Nutritional Deficiencies Among the Hamirpur Community
Published: 10/12/2024
Download PDF
Flowbite Logo
Najmal Complex,
Opposite Farwaniya,
Kuwait.
Email: support@himjournals.com

Useful Links
Order Hard Copy
Privacy policy
Terms and Conditions
Refund Policy
Others
About Us
Team Members
Contact Us
Online Payments
Join as Editor
Join as Reviewer
Subscribe to our Newsletter
Follow us
MOST SEARCHED KEYWORDS
scientific journal
 | 
business journal
 | 
medical journals
 | 
Scientific Journals
 | 
Academic Publisher
 | 
Peer-reviewed Journals
 | 
Open Access Journals
 | 
Impact Factor
 | 
Indexing Services
 | 
Journal Citation Reports
 | 
Publication Process
 | 
Impact factor of journals
 | 
Finding reputable journals for publication
 | 
Submitting a manuscript for publication
 | 
Copyright and licensing of published papers
 | 
Writing an abstract for a research paper
 | 
Manuscript formatting guidelines
 | 
Promoting published research
 | 
Publication in high-impact journals
Copyright © Himalayan Journals . All Rights Reserved.